Memo Therapeutics AG Identifies Potent SARS-CoV-2-Neutralizing Antibodies From the Blood of Recovered COVID-19 Patients Read more
Octapharma USA extends funding for COVID-19 study following positive preliminary research data Read more
Janssen’s TREMFYA delivers improvement in psoriatic arthritis joint and skin symptoms at week 52 in phase 3 trials Read more
FSD Pharma Receives FDA Approval to Design a Phase 2a Clinical Trial to Treat Patients with Suspected or Confirmed COVID-19 Diagnosis Read more
PharmAbcine signs a license agreement with Wincal Biopharm to expand indications of PharmAbcine’s existing assets to non-oncology areas Read more